Urogen Pharma Stock Forecast

Buy or Hold candidate since Jun 08, 2026 Gain 40.33%

The UroGen Pharma Ltd stock price fell by -6.94% on the last day (Friday, 31st Jul 2026) from $41.09 to $38.24. During the last trading day the stock fluctuated 8.11% from a day low at $38.02 to a day high of $41.11. The price has been going up and down for this period, and there has been a -4.95% loss for the last 2 weeks. Volume has increased on the last day by 397 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 815 thousand shares were bought and sold for approximately $31.15 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $37.68 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 60.63% during the next 3 months and, with a 90% probability hold a price between $60.53 and $73.99 at the end of this 3-month period.

URGN Signals & Forecast

The UroGen Pharma Ltd stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $40.80. On a fall, the stock will find some support from the long-term average at approximately $37.57. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 21, 2026, and so far it has fallen -12.65%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for UroGen Pharma Ltd stock

On the downside, the stock finds support just below today's level from accumulated volume at $34.54 and $31.33. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, UroGen Pharma Ltd finds support just below today's level at $34.54. If this is broken, then the next support from accumulated volume will be at $31.33 and $29.40.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.08 between high and low, or 8.11%. For the last week, the stock has had daily average volatility of 4.79%.

Our recommended stop-loss: $36.29 (-5.10%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (URGN) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect UroGen Pharma Ltd to open at $39.12, and during the day (based on 14 day Average True Range), to move between $37.27 and $39.21, which gives a possible trading interval of +/-$1.94 (+/-5.20%) up or down from last closing price. If UroGen Pharma Ltd takes out the full calculated possible swing range there will be an estimated 5.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $38.56 (0.84%) than the support at $34.54 (9.68%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is UroGen Pharma Ltd stock A Buy?

UroGen Pharma Ltd holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.750 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $39.12 ( 2.31%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk